Frontiers in Oncology | Hematologic Malignancies

Systematic Review

Published on 19 Sep 2025

Prognostic and clinicopathological value of prognostic nutritional index in patients with multiple myeloma: a meta-analysis

in Hematologic Malignancies

Yanchen Nie
Zongxin Zhang
Xiaohuan Tang

Frontiers in Oncology

doi 10.3389/fonc.2025.1545096

2,042 views

Case Report

Published on 18 Sep 2025

Case Report: A chronic myeloid leukemia patient with e8a2 BCR::ABL1 fusion transcript was successfully treated with Flumatinib

in Hematologic Malignancies

Shanfeng Hao
Yao Zhang
Qing Shao
Lijuan Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1670115

689 views

Case Report

Published on 18 Sep 2025

Venetoclax as a cytoreduction therapy option for acute promyelocytic leukemia in newly diagnosed adult patients: a case report of a 35-year-old female with schizophrenia

in Hematologic Malignancies

Lingling Wang
Yuqing Miao
Yuexin Cheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1671529

465 views

Case Report

Accepted on 17 Sep 2025

Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma: a case report

in Hematologic Malignancies

Marco Talarico
Gisella Vischini
Simona Barbato
Roberta Restuccia
Simone Masci
Ilaria Sacchetti
Enrica Manzato
Stefano Ghibellini
Michele Puppi
Miriam Iezza

Frontiers in Oncology

doi 10.3389/fonc.2025.1672690

421 views

Original Research

Accepted on 17 Sep 2025

Improvement of Revised International Staging System Risk Stratification in Patients with Newly Diagnosed Multiple Myeloma Using a High Bone Marrow Plasma Cell Percentage: A Real-World Study in China

in Hematologic Malignancies

Xiaoman Sun
Min Song
Pengyu Wang
Zhongmei Zhang
Jie Shi
Rongqin Dai

Frontiers in Oncology

doi 10.3389/fonc.2025.1627653

215 views

Case Report

Published on 17 Sep 2025

Case report: Histiocytic sarcoma as transdifferentiation of a marginal zone lymphoma—a case presentation based on post mortem examination and review of the literature

in Hematologic Malignancies

Annaïse J. Jauch
Ilaria Alborelli
Ilaria Balestri
Fatime Krasniqi
Alexandar Tzankov
Benjamin Kasenda
Thomas Menter

Frontiers in Oncology

doi 10.3389/fonc.2025.1609694

1,826 views

Original Research

Published on 17 Sep 2025

Integration of autophagy-related genes and immune dysregulation reveals a prognostic landscape in multiple myeloma

in Hematologic Malignancies

Yibo Xia
Dong Zheng
Xinyi Zhang
Shuxia Zhu
Enqing Lan
Hansen Ying
Zixing Chen
Bingxin Zhang
Shujuan Zhou
Yu Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1635596

321 views

Original Research

Published on 16 Sep 2025

A discrete choice experiment analysis to understand patient preferences for multiple myeloma treatments

in Hematologic Malignancies

Beth Faiman
Hoa H. Le
Julie Laurent
Saurabh Patel
Agne Paner-Straseviciute
Xinke Zhang
Joseph Mikhael

Frontiers in Oncology

doi 10.3389/fonc.2025.1628121

586 views

Case Report

Accepted on 15 Sep 2025

Acute Obinutuzumab-Induced Thrombocytopenia in Follicular Lymphoma: Case Report and Literature Review

in Hematologic Malignancies

Jieyi Zhou
Yi Zhang
Ce Xu
Rong Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1643313

210 views

Original Research

Accepted on 15 Sep 2025

The significance of PET/CT combined with machine learning models for the classification of lymphoma involvement and metastases in enlarged lymph nodes

in Hematologic Malignancies

Jingyi Ren
Jinbo Lu
Xun Shi
Yuexin Cheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1643924

120 views

Mini Review

Published on 15 Sep 2025

Factors affecting response and resistance to venetoclax in acute myeloid leukemia

in Hematologic Malignancies

Michael D. Diamantidis

Frontiers in Oncology

doi 10.3389/fonc.2025.1577908

765 views

Original Research

Accepted on 12 Sep 2025

Ibrutinib Combined with Rituximab and High-Dose Methotrexate (IRM) in Newly Diagnosed Primary CNS Diffuse Large B-Cell Lymphoma: A Pilot Study with Long-Term Follow-Up

in Hematologic Malignancies

Yixian Guo
Yongzhi Shan
Yueshan Piao
Xiaoli Chang
Dongmei Zou
Qiang Ma
Yukui Wei
Geng Xu
Yaming Wang
Dandan Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1669385

515 views

Perspective

Published on 12 Sep 2025

Enhancing diagnostics through flow cytometry: overcoming barriers in low resource settings

in Hematologic Malignancies

Jeanine Alfaro
Patricia Valverde
Paola Salguero
Xiomara Arevalo
Pamela Ortega
Luisa Sanchez
Federico Antillon-Klussmann
Randall T. Hayden
Alicia Rodriguez
Monika L. Metzger

Frontiers in Oncology

doi 10.3389/fonc.2025.1604295

813 views

Original Research

Published on 10 Sep 2025

Development of a novel prognostic model for mantle cell lymphoma based on quantitative detection of CD3 by quantitative dot blot

in Hematologic Malignancies

Ning Zhu
Yunjun Wang
Jiajia Hu
Xiaoyan Lin
Cuijuan Zhang
Fangrong Tang
Guohua Yu

Frontiers in Oncology

doi 10.3389/fonc.2025.1595572

958 views

Original Research

Published on 10 Sep 2025

Transcriptome-based immune subtypes reveal the heterogeneity of tumor microenvironment in pediatric B-cell acute lymphocytic leukemia

in Hematologic Malignancies

Hongbin Meng
Xiaoxia Li
Wenyi Hou
Jinqiao Li
Yueyue Fu

Frontiers in Oncology

doi 10.3389/fonc.2025.1643160

885 views

Original Research

Published on 10 Sep 2025

A retrospective analysis of inotuzumab ozogamicin usage in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

in Hematologic Malignancies

Narendra Agrawal
Pavan K. Boyella
Rahul Bhargava
Chandran K. Nair
Arijit Nag

Frontiers in Oncology

doi 10.3389/fonc.2025.1601782

947 views